Edges in Network
| Network | GSE16446_egf1520 - GSE16446 - SiGN-BN HC+Bootstrap |
| Network Description | Predicting the efficacy of anthracyclines in breast cancer (BC) patients: The results of the TOP trial |
| Node | NR3C1 |
| Upstream (Parents) |
|---|
| (<<) ATP2A2 → NR3C1 |
| (<<) MAP2K2 → NR3C1 |
| (<<) MAPKAPK5 → NR3C1 |
| (<<) MVK → NR3C1 |
| (<<) PIK3CD → NR3C1 |
| (<<) PRKCB → NR3C1 |
| (<<) PTGER4 → NR3C1 |
| (<<) RAVER1 → NR3C1 |
| (<<) STAT2 → NR3C1 |
| (<<) TUBB2C → NR3C1 |
| Downstream (Children) |
|---|
| NR3C1 → ADRBK2 (>>) |
| NR3C1 → ANKDD1A (>>) |
| NR3C1 → ARHGAP10 (>>) |
| NR3C1 → ARL4C (>>) |
| NR3C1 → CASP1 (>>) |
| NR3C1 → CAV3 (>>) |
| NR3C1 → CCND2 (>>) |
| NR3C1 → CD3EAP (>>) |
| NR3C1 → CDK4 (>>) |
| NR3C1 → CIRH1A (>>) |
| NR3C1 → CLEC2B (>>) |
| NR3C1 → CRLF3 (>>) |
| NR3C1 → CXCL14 (>>) |
| NR3C1 → CYP2U1 (>>) |
| NR3C1 → DHCR7 (>>) |
| NR3C1 → DNAJA1 (>>) |
| NR3C1 → EPHB4 (>>) |
| NR3C1 → FNBP1 (>>) |
| NR3C1 → GBP2 (>>) |
| NR3C1 → GNG10 (>>) |
| NR3C1 → GRK5 (>>) |
| NR3C1 → HLA-A (>>) |
| NR3C1 → HMGCS1 (>>) |
| NR3C1 → HRAS (>>) |
| NR3C1 → IL1R1 (>>) |
| NR3C1 → KCTD12 (>>) |
| NR3C1 → LIG1 (>>) |
| NR3C1 → LIMK1 (>>) |
| NR3C1 → LYPLA2 (>>) |
| NR3C1 → MAPK1 (>>) |
| NR3C1 → MMP15 (>>) |
| NR3C1 → MT1P2 (>>) |
| NR3C1 → PAG1 (>>) |
| NR3C1 → PCSK7 (>>) |
| NR3C1 → PLA2G4C (>>) |
| NR3C1 → PPP2R5C (>>) |
| NR3C1 → PPP3CC (>>) |
| NR3C1 → RAP1A (>>) |
| NR3C1 → RBL2 (>>) |
| NR3C1 → ROCK1 (>>) |
| NR3C1 → RORA (>>) |
| NR3C1 → RYK (>>) |
| NR3C1 → SERPINB1 (>>) |
| NR3C1 → SRC (>>) |
| NR3C1 → STK4 (>>) |
| NR3C1 → STX12 (>>) |
| NR3C1 → SYK (>>) |
| NR3C1 → TMCC3 (>>) |
| NR3C1 → TUBA1C (>>) |
